Moreover, the insulin‐like growth factor‐1 receptor (IGF‐1R) is involved in the regulation of Hippo–YAP signaling in diffuse large B‐cell lymphoma (DLBCL) tumorigenesis.78 Here, IGF1R is linked to diffuse large B-cell lymphoma.